Katherine Deck

Suggest Changes
  • Citations Per Year
Learn More
47 Background: MammaPrint (MP) is a powerful predictor of disease outcome in early stage breast cancer. In addition, TargetPrint (TP), a microarray-based test that measures the mRNA expression level(More)
  • 1